1 study found for:    PANCREATIC GS 6624 MARYLAND
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Interventions: Drug: Simtuzumab;   Drug: Gemcitabine;   Drug: Placebo to match simtuzumab

Indicates status has not been verified in more than two years